Summit Cosmetics Corporation (SCC), a global cosmetic ingredient developer and distributor, announced today that it has executed a global distribution agreement with NXTLEVVEL, a commercial scale manufacturer of next generation biomass derived chemicals, for the distribution of its NXT SOLV product line to the Beauty and Personal Care industry. The agreement is for a five-year term and grants sales rights to SCC and its sister cosmetic companies, all of which are Sumitomo Corporation Group Companies.

The products included in the agreement are as follows:

NXT SOLV 120

NXT SOLV 220

NXT SOLV 320

NXT SOLV 420

"This partnership with NXTLEVVEL will allow us to diversify our existing portfolio to better-meet the demands of consumers and our customers as the industry – and world – seek more sustainable solutions and technologies," said Shohei Shibukawa, Global President & Officer of Summit Cosmetic Corporation.

NXTLEVVEL has developed world-leading technology in bio-solvents based on levulinic acid. These affordable bio-based chemicals are essential to reduce dependence on fossil fuels and will play a critical role in the reduction of carbon emissions. As an alternative to traditional solvents, NXTLEVVEL's products offer outstanding benefits for personal care formulations, whilst addressing the needs of environmentally conscious consumers and adding value for brand owners. Benefits of NXTLEVVEL bio-solvents include:

• Ability to dissolve a wide range of active ingredients
• Allow increased concentration of actives
• Enables high water loading for moisturizing formulations by incorporating water into anhydrous systems
• Expands solubility of ethanol, while retaining clarity
• Enhances natural formulations by reducing greasiness, providing a dry, silky after-feel

"I'm very excited that NXTLEVVEL and SCC are embarking on a relationship to promote our range of biobased solvents in the Beauty and Personal Care industry by leveraging the strength of our technology along with SCC's global reach and relationships," commented Aris de Rijke, CEO of NXTLEVVEL Biochem.  "This agreement will grant our product line access to new markets and customers that can take advantage of our innovative, biobased solutions."